Search results
Combining biomedical data from breast cancer patients could lead to 'groundbreaking discoveries'
Medical Xpress· 2 hours agoBreast cancer is one of the leading causes of death of women globally—accounting for 685,000 deaths...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon -...
Benzinga· 1 hour agoOn Friday, Pfizer Inc PFE revealed its drug for an advanced form of lung cancer showed promising...
How Sarah Ferguson’s “Honest and Frank” Relationship With Princess Eugenie and Beatrice Helped with ...
Vanity Fair· 1 hour agoIn the midst of several serious health issues amongst members of the royal family, namely the cancer...
Olivia Munn Details Being "Devastated" Over Her Reconstructive Breast Surgery - E! Online
E! Online· 45 minutes agoMonths after revealing her breast cancer diagnosis, the ‘Newsroom’ alum appears on the “SheMD’...
GLP-1 receptor agonists: Are they friends or foes in colorectal cancer?
MedicalNewsToday via AOL· 3 hours agoA new study in mice suggests that blocking the GLP-1 receptor may help defend against colorectal ...
NIH Scientists Develop AI Tool to Predict How Cancer Patients will Respond to Immunotherapy
Sierra Sun Times· 5 hours agoIn a proof-of-concept study, researchers at the National Institutes of Health (NIH) have developed...
“Monstrous” Discovery: Scientists Identify Key to Stopping Cancer Recurrence
SciTechDaily· 11 hours agoScientists have discovered that polyploid giant cancer cells, which are monstrously oversized and...
Weight loss jabs have 'enormous potential' to cut risk of obesity-related cancer
Daily Express· 2 hours agoWeight loss jabs such as Ozempic have “enormous potential” as a new weapon in the fight against ...
Alonzo Mourning had prostate removed after cancer diagnosis
New York Times· 5 hours agoAlonzo Mourning, a Basketball Hall of Famer, had surgery to remove his prostate after a Stage 3...
New bowel tumor drug helped cure cancer in 100% of cases
BGR· 1 hour agoA drug called Jemperli (dostarlimab) showed impressive results in a phase 2 trial at the Memorial...